[Pharmacology, pharmacokinetics and toxicology of the new antihistaminic HS 592 (Tavegil)].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001769:Blood / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004487:Edema / Q000188:drug therapy*; D005260:Female; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology* / Q000633:toxicity*; D008297:Male; D051379:Mice; D011817:Rabbits; D012702:Serotonin Antagonists
D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D000109:Acetylcholine
Farmacologia, farmacocinetica e tossicologia del nuovo antistaminico HS592 (Tavegil)